WEST PHARM.SVCS DL-,25/ US9553061055 /
| 2024-05-17 9:59:36 PM | Chg. +3.100 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 324.300EUR | +0.97% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 23.83 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 7.98 USD | 1.40% |
| EPS Diluted: | 7.88 USD | 1.94% |
| Revenues per Share: | 40.24 USD | 3.34% |
| Book Value per Share: | 39.30 USD | 8.53% |
| Cash Flow per Share: | 10.59 USD | 8.48% |
| Dividend per Share: | 0.78 USD | 5.41% |
| Total | in mill. | |
| Revenues: | 2,949.80 USD | 2.18% |
| Net Income: | 593.40 USD | 1.28% |
| Operating Cash Flow: | 776.50 USD | - |
| Cash and Cash Equivalents: | 853.90 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 44.57 | 44.13 |
| P/S Ratio: | 8.84 | 8.75 |
| P/BV ratio: | 9.05 | 8.96 |
| P/CF Ratio: | 33.57 | 33.24 |
| PEG: | 31.89 | 31.57 |
| Earnings Yield: | 2.24% | 2.27% |
| Dividend Yield: | 0.22% | 0.22% |
| Market Capitalization | ||
| Market Capitalization: | 23.83 bill. EUR | 23.38 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 72.84 mill. | |
Profitability
| Gross Profit Margin: | 38.28% |
| EBIT Margin: | 22.92% |
| Net Profit Margin: | 20.12% |
| Return on Equity: | 20.60% |
| Return on Assets: | 15.50% |
Financial Strength
| Liquidity I / Cash Ratio: | 127.11% |
| Liquidity II / Quick Ratio: | 203.32% |
| Liquidity III / Current Ratio: | 288.24% |
| Debt / Equity Ratio: | 32.92% |
| Dynam. Debt / Equity Ratio: | 122.15% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
